Check-Cap Ltd. (CHEK) Reaches $0.85 52 Week Low; ACONEX LTD ORD AUSTRALIA (ACNXF) Shorts Raised By 0.07%

December 6, 2017 - By Linda Rogers

ACONEX LTD ORD AUSTRALIA (OTCMKTS:ACNXF) had an increase of 0.07% in short interest. ACNXF’s SI was 3.87 million shares in December as released by FINRA. Its up 0.07% from 3.87M shares previously. With 3,400 avg volume, 1138 days are for ACONEX LTD ORD AUSTRALIA (OTCMKTS:ACNXF)’s short sellers to cover ACNXF’s short positions. It closed at $3.72 lastly. It is down 0.00% since December 6, 2016 and is . It has underperformed by 16.70% the S&P500.

The stock of Check-Cap Ltd. (NASDAQ:CHEK) hit a new 52-week low and has $0.82 target or 4.00% below today’s $0.85 share price. The 5 months bearish chart indicates high risk for the $16.37M company. The 1-year low was reported on Dec, 6 by If the $0.82 price target is reached, the company will be worth $654,800 less. The stock decreased 7.61% or $0.07 during the last trading session, reaching $0.85. About 143,330 shares traded. Check-Cap Ltd. (NASDAQ:CHEK) has declined 2.26% since December 6, 2016 and is downtrending. It has underperformed by 18.96% the S&P500.

Among 4 analysts covering Check-Cap (NASDAQ:CHEK), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Check-Cap has $18 highest and $4 lowest target. $5.13’s average target is 503.53% above currents $0.85 stock price. Check-Cap had 10 analyst reports since July 22, 2015 according to SRatingsIntel. On Tuesday, November 28 the stock rating was maintained by H.C. Wainwright with “Buy”. Chardan Capital Markets maintained Check-Cap Ltd. (NASDAQ:CHEK) on Wednesday, March 16 with “Buy” rating. The firm has “Buy” rating given on Thursday, September 28 by H.C. Wainwright. The stock of Check-Cap Ltd. (NASDAQ:CHEK) has “Buy” rating given on Friday, May 20 by Chardan Capital Markets. Maxim Group initiated Check-Cap Ltd. (NASDAQ:CHEK) on Thursday, October 8 with “Buy” rating. The firm earned “Buy” rating on Wednesday, July 22 by Chardan Capital Markets. The company was maintained on Tuesday, May 30 by Maxim Group. Maxim Group maintained Check-Cap Ltd. (NASDAQ:CHEK) on Tuesday, January 19 with “Buy” rating. The rating was maintained by H.C. Wainwright on Friday, August 11 with “Buy”. Rodman & Renshaw initiated the stock with “Buy” rating in Thursday, January 19 report.

Analysts await Check-Cap Ltd. (NASDAQ:CHEK) to report earnings on March, 8. They expect $-0.14 earnings per share, up 6.67% or $0.01 from last year’s $-0.15 per share. After $-0.13 actual earnings per share reported by Check-Cap Ltd. for the previous quarter, Wall Street now forecasts 7.69% negative EPS growth.

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of an ingestible imaging capsule that utilizes low-dose X-rays for screening of the colon to detect polyps, masses, and colorectal cancers. The company has market cap of $16.37 million. The Company’s C-Scan system consists of C-Scan Cap, an X-ray scanning capsule, which is designed to measure, collect, and transmit structural information; C-Scan Track, a biocompatible unit that is designed to track the capsule and record imaging and positioning data; and C-Scan View, a personal computer software package, which is designed to retrieve and process clinical data from the C-Scan Track, and to reconstruct and produce 3D visualization of the colonÂ’s inner surface. It currently has negative earnings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Linda Rogers

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: